FDA
-
-
-
-
-
-
-
MYOS RENS Technology Reports First Quarter 2020 Financial Results Including a 95% Increase in Net Revenues
-
-
-
-
-
-
-
MYOS RENS Technology Reports 75% Net Revenue Growth in Second Quarter, 109% Net Revenue Growth in First Half of 2019
-
-
-
-
-
-
-
MYOS RENS Technology Announces the Date for the Release of First Quarter 2019 Results, Conference Call and Webcast
-
-
-
-
-
-
-
MYOS CEO Joseph Mannello Issues Letter to Shareholders Following Presentation at North American Veterinary Community (NAVC) Conference/VMX
-
-
-
-
-
-
-
MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders
-
-
-
-
-
-
-
Centers For Medicare and Medicaid Services Approves Reimbursement For Unique Fortetropin®-Based Enteral Nutrition Formula
-
-
-
-
-
-
-
MYOS RENS Technology Announces the Date for the Release of First Quarter 2018 Results, Conference Call and Webcast
-
322,978 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

